Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in (Q57243499)
Jump to navigation
Jump to search
scholarly article by Kim Fox et al published November 2006 in American Heart Journal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in |
scholarly article by Kim Fox et al published November 2006 in American Heart Journal |
Statements
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in (English)
0 references
November 2006
0 references
152
0 references
5
0 references
860-866
0 references